|
Synonyms: compound 33 [PMID: 37974956]
Compound class:
Synthetic organic
Comment: MR-L2 is a prototypical allosteric activator of PDE4 long-form cyclic AMP phosphodiesterases [3]. It is representative of proprietary LoAc® small molecules that are being developed Mironid [2]. LoAc® activators are proposed to increase the hydrolysis of cAMP (catalysed by long-form PDE4 enzymes encoded by PDE4A, PDE4B, PDE4C, and PDE4D), and are intended to reduce cAMP-driven cyst formation in autosomal dominant polycystic kidney disease (ADPKD).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| MR-L2 reduces PGE2-induced MDCK cell cyst formation with an EC50 of 1.2 μM [3]. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||